Results 61 to 70 of about 881,201 (350)

Neonatal Myocardial Infarction or Myocarditis? [PDF]

, 2011
We report a 29 week-gestation preterm infant who presented during his second week of life with cardiogenic shock. Clinical presentation and first diagnostics suggested myocardial infarction, but echocardiographic features during follow-up pointed to a ...
A Arthur, A Tillett, AJ Tometzki, Albertus Timmer, Beatrijs Bartelds, C Berry, D Bernstein, D Garel, D Inwald, DM Saker, DW Sapire, GE Burch, H Kilbride, IM Baldew, J Boulton, J Hruda, JM Morgan, Joost P. van Melle, KL Baughman, Klasien A. Bergman, L Abdurrahman, LA Iannone, Leanne de Vetten, LF Fagan, LG Hauwert Van der, M Fletcher, M Nathan, M Schryer, M Takeuchi, MH Gault, MZ Akkad, ND Reich, Nynke J. Elzenga, PF Lehoullier, S Ferns, S Sandhyamani, SJ Murugan, TS Hornung, VW Lucas Jr, WL Hu   +39 more
core   +2 more sources

ANMCO POSITION PAPER: Role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock [PDF]

, 2021
The treatment of patients with advanced acute heart failure is still challenging. Intra-aortic balloon pump (IABP) has widely been used in the management of patients with cardiogenic shock.
Baldi C., Caldarola P., Chiappetta D., Cipriani M., Colivicchi F., Ferlini M., Gabrielli D., Gasparetto N., Gilardi R., Giubilato S., Gulizia M. M., Imazio M., Marini M., Roncon L., Rossini R., Scotto Di Uccio F., Somaschini A., Sorini Dini C., Trambaiolo P., Usmiani T., Valente S.   +20 more
core   +1 more source

Safety and efficacy of istaroxime in patients with acute heart failure‐related pre‐cardiogenic shock – a multicentre, randomized, double‐blind, placebo‐controlled, parallel group study (SEISMiC)

European Journal of Heart Failure, 2022
We examined the effects of istaroxime in patients hospitalized for acute heart failure (AHF) related Society for Cardiovascular Angiography and Interventions (SCAI) stage B pre‐cardiogenic shock (CS).
M. Metra, O. Chioncel, G. Cotter, B. Davison, G. Filippatos, A. Mebazaa, Maria Novosadova, P. Ponikowski, P. Simmons, J. Soffer, S. Simonson   +10 more
semanticscholar   +1 more source

Efficiency of Renal Replacement Therapy for Cardiogenic Shock Complicated by Multiorgan Dysfunction

Общая реаниматология, 2011
Objective: to analyze the efficiency of renal replacement therapy (RRT) for acute myocardial infarction complicated by cardiogenic shock and multiorgan dysfunction. Subjects and methods.
L. S. Barbarash, A. N. Popkov, V. Yu., Kheraskov, G. P. Plotnikov, D. L. Shukevich, E. V. Grigoryev   +5 more
doaj   +1 more source

Cardiogenic shock among cancer patients

Frontiers in Cardiovascular Medicine, 2022
Sophisticated cancer treatments, cardiovascular risk factors, and aging trigger acute cardiovascular diseases in an increasing number of cancer patients.
Anais Curtiaud, Clement Delmas, Justine Gantzer, Lara Zafrani, Martin Siegemund, Martin Siegemund, Ferhat Meziani, Ferhat Meziani, Hamid Merdji, Hamid Merdji   +9 more
doaj   +1 more source

Cardiogenic shock and nutrition: safe? [PDF]

, 2018
Cardiogenic shock is a common diagnosis in patients in the intensive care unit (ICU), and is characterized by a decreased cardiac output in the presence of adequate intravascular volume associated with an inadequate tissue perfusion including a ...
Bendjelid, Karim, Pichard, Claude, Thibault, Ronan, Wernerman, Jan   +3 more
core  

Coxsackie B2 Virus Infection Causing Multiorgan Failure and Cardiogenic Shock in a 42-Year-Old Man [PDF]

, 2019
Infections from coxsackie B2 viruses often cause viral myocarditis and, only rarely, multisystem organ impairment. We present the unusual case of a 42-year-old man in whom coxsackie B2 virus infection caused multiorgan infection, necessitating distal ...
Abdou, Mahmoud H., Hadi, M. Azam, Hopkins, Kali A.   +2 more
core   +1 more source

Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association

Circulation
Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in ...
V. Blumer, Manreet K. Kanwar, Christopher F. Barnett, Jennifer Cowger, Abdulla A Damluji, Maryjane A. Farr, Sarah J. Goodlin, Jason N. Katz, C. McIlvennan, S. Sinha, Tracy Y Wang   +10 more
semanticscholar   +1 more source

Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association

Circulation, 2021
Supplemental Digital Content is available in the text. Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic
T. Henry, Matthew I Tomey, J. Tamis-Holland, H. Thiele, S. Rao, V. Menon, D. Klein, Y. Naka, I. Piña, N. Kapur, G. Dangas   +10 more
semanticscholar   +1 more source

Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy

British Journal of Clinical Pharmacology, EarlyView.
Aims Amlodipine poisoning is a leading cause of cardiovascular medication‐related deaths, commonly managed with high‐dose insulin (HDI) therapy. However, HDI is a vasodilator that is counterproductive in managing vasoplegia. We aim to study HDI therapy in patients with hypotension following dihydropyridine calcium channel antagonist (CCA) overdose ...
Betty S. H. Chan, Katherine Z. Isoardi, Darren M. Roberts, Ong Sook Har   +3 more
wiley   +1 more source